These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 7115598)
21. Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts. Teicher BA; Menon K; Alvarez E; Galbreath E; Shih C; Faul M Clin Cancer Res; 2001 Mar; 7(3):634-40. PubMed ID: 11297259 [TBL] [Abstract][Full Text] [Related]
22. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity. Teicher BA; Bernal SD; Holden SA; Cathcart KN Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032 [TBL] [Abstract][Full Text] [Related]
23. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115 [TBL] [Abstract][Full Text] [Related]
24. Combined growth-inhibitory responses and ultrastructural alterations produced by 1,3-bis(2-chloroethyl)-1-nitrosourea and dexamethasone in rat glioma cell cultures. Grasso RJ; Johnson CE; Boler RK; Moore NA Cancer Res; 1977 Feb; 37(2):585-94. PubMed ID: 832280 [TBL] [Abstract][Full Text] [Related]
25. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Westphal M; Ram Z; Riddle V; Hilt D; Bortey E; Acta Neurochir (Wien); 2006 Mar; 148(3):269-75; discussion 275. PubMed ID: 16482400 [TBL] [Abstract][Full Text] [Related]
26. [Experimental study of combination therapy against human glioma xenograft by differentiation-inducing agent and cytotoxic chemotherapeutic drug]. Shi MG; Huang Q; Dong J; Sun ZF; Lan Q Ai Zheng; 2002 Oct; 21(10):1090-4. PubMed ID: 12508650 [TBL] [Abstract][Full Text] [Related]
27. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model. Bullard DE; Bigner SH; Bigner DD Cancer Res; 1985 Nov; 45(11 Pt 1):5240-5. PubMed ID: 4053004 [TBL] [Abstract][Full Text] [Related]
28. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor. Marton LJ; Levin VA; Hervatin SJ; Koch-Weser J; McCann PP; Sjoerdsma A Cancer Res; 1981 Nov; 41(11 Pt 1):4426-31. PubMed ID: 6796258 [TBL] [Abstract][Full Text] [Related]
29. Improved treatment of a brain-tumor model. Part 2: Sequential therapy with BCNU and 5-fluorouracil. Gerosa MA; Dougherty DV; Wilson CB; Rosenblum ML J Neurosurg; 1983 Mar; 58(3):368-73. PubMed ID: 6827321 [TBL] [Abstract][Full Text] [Related]
30. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma. Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116 [TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813 [TBL] [Abstract][Full Text] [Related]
32. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity. Teicher BA; Crawford JM; Holden SA; Cathcart KN Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of single-bolus vs. frequent low-dose treatment with nitrosourea in experimental gliomas. Wu CM; Inamura T; Ikezaki K; Nakamizo A; Inoha S; Yaosaka F; Fukui M Anticancer Res; 2001; 21(3B):1835-8. PubMed ID: 11497267 [TBL] [Abstract][Full Text] [Related]
34. Combination chemotherapy of BCNU and Didox acts synergystically in 9L glioma cells. Horvath Z; Bauer W; Hoechtl T; Saiko P; Fritzer-Szekeres M; Tihan T; Szekeres T Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1531-5. PubMed ID: 15571292 [TBL] [Abstract][Full Text] [Related]
35. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea, a novel chloroethylnitrosourea analogue with enhanced antitumor activity against human glioma xenografts. Marcantonio D; Panasci LC; Hollingshead MG; Alley MC; Camalier RF; Sausville EA; Dykes DJ; Carter CA; Malspeis L Cancer Res; 1997 Sep; 57(18):3895-8. PubMed ID: 9307267 [TBL] [Abstract][Full Text] [Related]
36. Concurrent treatment with BCNU and Gamma Knife radiosurgery in the rat malignant glioma model. Cho KT; Kim DG; Paek SH; Chung HT; Jung HW; Park HW J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):132-41. PubMed ID: 22628080 [TBL] [Abstract][Full Text] [Related]
37. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. Murphy S; Boyle FM; Davey RA; Gu XQ; Mather LE J Pharm Pharmacol; 2007 Jan; 59(1):105-14. PubMed ID: 17227627 [TBL] [Abstract][Full Text] [Related]
38. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation. Morton JD; Porter E; Yabuki H; Nath R; Rockwell S Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353 [TBL] [Abstract][Full Text] [Related]
39. [Histopathological and autoradiographical studies of experimental brain tumors after continuous local chemotherapy--acute stage in rat models]. Shimura T; Teramoto A; Aihara K Gan To Kagaku Ryoho; 1997 Apr; 24(6):713-8. PubMed ID: 9126309 [TBL] [Abstract][Full Text] [Related]
40. Effects of alpha-difluoromethylornithine on the growth of 9L rat brain tumor multicellular spheroids and their response to 1,3-bis(2-chloroethyl)-1-nitrosourea. Sano Y; Deen DF; Oredsson SM; Marton LJ Cancer Res; 1984 Feb; 44(2):577-81. PubMed ID: 6420048 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]